In contrast, we did not observe any Hb improvement over time in patients with" functional iron deficiency", despite increased use of EPO: this group had overall the lowest Hb (except at baseline, month 3, 4 and 8) together with the highest dose of EPO (except at baseline). The gene discussed is GSTM1; the disease is Iron deficiency anemia.